BIOMARIN PHARMACEUTICAL INC 10-Q filing
Filed 2025-08-05 · Report date 2025-06-30 · 2025
Filing metadata
- Accession number
- 0001048477-25-000090
- Form type
- 10-Q
- CIK
- 0001048477
- Primary document
- https://www.sec.gov/Archives/edgar/data/1048477/000104847725000090/bmrn-20250630.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for BIOMARIN PHARMACEUTICAL INC.
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $1.6B | - | - |
| Cost Of Revenue | $301.6M | - | - |
| Operating Income | $500.8M | - | - |
| Net Income | $426.2M | - | - |
| Eps Basic | 2.23 | - | - |
| Eps Diluted | 2.19 | - | - |
| Cash And Equivalents | $1.2B | - | - |
| Total Assets | $7.5B | - | - |
| Total Liabilities | $1.4B | - | - |
| Shareholders Equity | $6.0B | - | - |
| Operating Cash Flow | $359.7M | - | - |
| Capital Expenditures | $33.9M | - | - |